Statins and Diabetes Risk
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Statins are a class of drugs that inhibit the HMG Co-A reductase enzyme and subsequently reduce the cholesterol levels.HMG Co-A reductase enzyme is involved in the cholesterol synthesis in the liver and accounts for 70% of the production of total body cholesterol.High cholesterol levels attribute to cardiovascular disease in high-risk individuals.Statins have been found to reduce CVD endpoints in the initial stages of the disease (secondary prevention) but evidence is still weak to support statin therapy in those without CVD but with high cholesterol levels (primary prevention).Statins are also associated with certain adverse effects like muscle pain, incident diabetes and elevated liver enzymes and occasionally muscle damage; although very rare.In this review I shall explore one of these adverse effects of statin therapy particularly the link between statins and incident diabetes in the following report and try to shed some light into this controversial topic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Rajpathak, S. N., Kumbhani, D. J., Crandall, J., Barzilai, N., Alderman, M., & Ridker, P. M. (2009) · Diabetes Care · doi:10.2337/dc09-0738 · Cited by 439
Cited by
Inhibiting PCSK9 — biology beyond LDL control
Stoekenbroek, R. M., Lambert, G., Cariou, B., & Hovingh, G. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0110-5 · Cited by 141
Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
Krähenbühl, S., Pavik-Mezzour, I., & von Eckardstein, A. (2016) · Drugs · doi:10.1007/s40265-016-0613-0 · Cited by 89
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better
Grundy, S. M., Stone, N. J., Blumenthal, R. S., Braun, L. T., Heidenreich, P. A., Lloyd-Jones, D., Orringer, C. E., Saseen, J. J., Smith, S. C., Sperling, L. S., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.02.032 · Cited by 20
Metadata
- Authors
- Rahman Chowdhury, S.
- Venue
- Journal of Endocrinology and Thyroid Research
- Publisher
- Juniper Publishers
- Published
- 2021-02-25
- Volume
- 5
- Issue
- 5
- Pages
- 79-80
- ISSN
- 2573-2188 (ISSN-L)
- OpenAlex
- W4232424184
- Cited by
- 40
- References
- 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statins and Diabetes Risk. https://app.cochat.ai/papers/10.19080/jetr.2021.05.555674
- The paper
- Rahman Chowdhury, S. (2021). Statins and Diabetes Risk. Journal of Endocrinology and Thyroid Research. https://doi.org/10.19080/jetr.2021.05.555674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.